[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

US Diabetes Monitoring, Treatment and Drug Delivery Market - 2014

April 2014 | 212 pages | ID: UC3AD777CA2EN
iData Research Inc.

US$ 6,995.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The diabetes monitoring, treatment and drug delivery market is segmented into eight categories. Among these, growing segments included the continuous glucose monitoring (CGM), insulin pump and supplies, modern insulin, insulin pens and pen needle markets. These segments have one aspect in common: they are newer ways of treating diabetes. CGM and pump technologies are improving at a fast pace toward full integration and automatic insulin suspension. Modern insulin is rapidly replacing human insulin due to its superior qualities. Insulin pens are replacing insulin syringes because they are discreet, more accurate and require less time. These segments will drive the overall market up through 2020.
EXECUTIVE SUMMARY

1.1 U.S. MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY
1.2 GROWTH TRENDS BY SEGMENT
1.3 BLOOD GLUCOSE TEST STRIP MARKET
1.4 MODERN INSULIN MARKET
1.5 INSULIN SYRINGE MARKET
1.6 INSULIN PEN NEEDLE MARKET
1.7 INSULIN PUMP-CGM INTEGRATION MARKET
1.8 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-  Step METHODOLOGY
  Step 1: Project Initiation & Team Selection
  Step 2: Prepare Data Systems and Perform Secondary Research
  Step 3: Preparation for Interviews & Questionnaire Design
  Step 4: Performing Primary Research
  Step 5: Research Analysis: Establishing Baseline Estimates
  Step 6: Market Forecast and Analysis
  Step 7: Identify Strategic Opportunities
  Step 8: Final Review and Market Release
  Step 9: Customer Feedback and Market Monitoring

U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET

3.1 INTRODUCTION
  3.1.1 Types of Diabetes
  3.1.2 Diabetes Complications
  3.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
  3.1.4 Signs and Symptoms
  3.1.5 Diabetes Monitoring
  3.1.6 Treatment
  3.1.7 Drug Delivery Systems
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS
3.4 DRIVERS AND LIMITERS
  3.4.1 Market Drivers
  3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.6 HERFINDAHL INDEX
3.7 MERGERS AND ACQUISITIONS

TRADITIONAL BLOOD GLUCOSE METER MARKET

4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
  4.3.1 Total Traditional Blood Glucose Meter Market
  4.3.2 Professional Blood Glucose Meter Market
  4.3.3 Personal Blood Glucose Meter Market
4.4 DRIVERS AND LIMITERS
  4.4.1 Market Drivers
  4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS

TRADITIONAL BLOOD GLUCOSE TEST STRIP MARKET

5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
  5.3.1 Total Blood Glucose Test Strip Market
  5.3.2 Professional Blood Glucose Test Strip Market
  5.3.3 Total Personal Blood Glucose Test Strip Market
    5.3.3.1 Medicare/Medicaid Blood Glucose Test Strip Market
    5.3.3.2 Managed Care Blood Glucose Test Strip Market
    5.3.3.3 Cash Blood Glucose Test Strip Market
5.4 UNIT SALES ANALYSIS: LONG-TERM CARE BLOOD GLUCOSE TEST STRIPS
5.5 DRIVERS AND LIMITERS
  5.5.1 Market Drivers
  5.5.2 Market Limiters
5.6 COMPETITIVE ANALYSIS

LANCET AND LANCING DEVICE MARKET

6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
  6.3.1 Total Lancet and Lancing Device Market
  6.3.2 Professional Lancet and Lancing Device Market
  6.3.3 Personal Lancet and Lancing Device Market
6.4 DRIVERS AND LIMITERS
  6.4.1 Market Drivers
  6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS

CONTINUOUS GLUCOSE MONITORING MARKET

7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
  7.3.1 Continuous Glucose Monitoring System Market
  7.3.2 Continuous Glucose Monitoring Sensor Market
  7.3.3 Emerging Market: Intravascular Continuous Glucose Monitoring Market
  7.3.4 Emerging Market: Pump-CGM Integration (First Generation Artificial Pancreas)
7.4 DRIVERS AND LIMITERS
  7.4.1 Market Drivers
  7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS

INSULIN PUMP MARKET

8.1 INTRODUCTION
  8.1.1 Traditional Insulin Pumps
  8.1.2 Insulin Patch Pumps
  8.1.3 Simple Pumps
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
  8.3.1 Total Traditional Insulin Pump Market
    8.3.1.1 Traditional Insulin Pump (Device) Market
    8.3.1.2 Traditional Insulin Pump Infusion Set Market
    8.3.1.3 Traditional Insulin Pump Reservoir Market
  8.3.2 Total Patch Insulin Pump Market
    8.3.2.1 Patch Pump Controller Market
    8.3.2.2 Insulin Pod Market
  8.3.3 Simple Insulin Pump Market
8.4 DRIVERS AND LIMITERS
  8.4.1 Market Drivers
  8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS

MODERN INSULIN MARKET

9.1 INTRODUCTION
  9.1.1 Insulin Types
    9.1.1.1 Long-Acting Insulin Analogs
    9.1.1.2 Rapid-Acting Insulin Analogs
    9.1.1.3 Premixed Insulin Analogs
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
  9.3.1 Total Modern Insulin Market
  9.3.2 Long-Acting Modern Insulin Market
  9.3.3 Rapid-Acting Modern Insulin Market
  9.3.4 Premixed Modern Insulin Market
9.4 DRIVERS AND LIMITERS
  9.4.1 Market Drivers
  9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS

INSULIN SYRINGE MARKET

10.1 INTRODUCTION
10.2 MARKET OVERVIEW
10.3 MARKET ANALYSIS AND FORECAST
  10.3.1 Total Insulin Syringe Market
  10.3.2 Professional Insulin Syringe Market
  10.3.3 Personal Insulin Syringe Market
10.4 DRIVERS AND LIMITERS
  10.4.1 Market Drivers
  10.4.2 Market Limiters
10.5 COMPETITIVE ANALYSIS

MODERN INSULIN PEN MARKET

11.1 INTRODUCTION
11.2 MARKET ANALYSIS AND FORECAST
  11.2.1 Total Modern Insulin Pen Market
  11.2.2 Prefilled Pen Market
  11.2.3 Pen Cartridge Market
  11.2.4 Reusable Pen Market
  11.2.5 Pen Needle Market
11.3 DRIVERS AND LIMITERS
  11.3.1 Market Drivers
  11.3.2 Market Limiters
11.4 COMPETITIVE ANALYSIS

ABBREVIATIONS


LIST OF CHARTS

Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2010 – 2020
Chart 1 2: Growth Trends by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2010 – 2020
Chart 1 3: Units Sold (Millions), Personal Blood Glucose Test Strip Market, U.S., 2013 – 2016
Chart 1 4: Unit Sales vs ASP vs Market Value by Segment, Modern Insulin Market, U.S., 2013
Chart 1 5: Insulin Syringe Market by Segment, U.S., 2013 – 2016
Chart 1 6: Units Sold, Insulin Pen Needle Market, U.S., 2013 – 2016
Chart 1 7: Insulin Pump Market by Segment, U.S., 2013 – 2016
Chart 1 8: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013
Chart 3 1: Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, U.S., 2010 – 2020
Chart 3 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Breakdown, U.S., 2013
Chart 3 3: Diabetes Diagnosis, Treatment and Drug Delivery Market Breakdown, U.S., 2020
Chart 3 4: Diabetes Diagnosis, Treatment and Drug Delivery Market Growth by Segment U.S., 2010 – 2020
Chart 3 5: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, U.S., 2013
Chart 3 6: Herfindahl Index, Diabetes Diagnosis, Treatment and Drug Delivery Market, U.S., 2013
Chart 4 1: Traditional Blood Glucose Meter Market by Segment, U.S., 2010 – 2020
Chart 4 2: Traditional Blood Glucose Meter Market Breakdown, U.S., 2013
Chart 4 3: Traditional Blood Glucose Meter Market Breakdown, U.S., 2020
Chart 4 4: Total Traditional Blood Glucose Meter Market, U.S., 2010 – 2020
Chart 4 5: Professional Blood Glucose Meter Market, U.S., 2010 – 2020
Chart 4 6: Personal Blood Glucose Meter Market, U.S., 2010 – 2020
Chart 4 7: Leading Competitors, Traditional Blood Glucose Meter Market, U.S., 2013
Chart 5 1: Blood Glucose Test Strip Market by Segment, U.S., 2010 – 2020
Chart 5 2: Blood Glucose Test Strip Market Breakdown, U.S., 2013
Chart 5 3: Blood Glucose Test Strip Market Breakdown, U.S., 2020
Chart 5 4: Total Blood Glucose Test Strip Market, U.S., 2010 – 2020
Chart 5 5: Professional Blood Glucose Test Strip Market, U.S., 2010 – 2020
Chart 5 6: Total Personal Blood Glucose Test Strip Market, U.S., 2010 – 2020
Chart 5 7: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2010 – 2020
Chart 5 8: Managed Care Blood Glucose Test Strip Market, U.S., 2010 – 2020
Chart 5 9: Cash Blood Glucose Test Strip Market, U.S., 2010 – 2020
Chart 5 10: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2013
Chart 6 1: Lancet and Lancing Device Market by Segment, U.S., 2010 – 2020
Chart 6 2: Lancet and Lancing Device Market Breakdown, U.S., 2013
Chart 6 3: Lancet and Lancing Device Market Breakdown, U.S., 2020
Chart 6 4: Total Lancet and Lancing Device Market, U.S., 2010 – 2020
Chart 6 5: Professional Lancet and Lancing Device Market, U.S., 2010 – 2020
Chart 6 6: Personal Lancet and Lancing Device Market, U.S., 2010 – 2020
Chart 6 7: Leading Competitors, Lancet and Lancing Device Market, U.S., 2013
Chart 7 1: Continuous Glucose Monitoring Market by Segment, U.S., 2010 – 2020
Chart 7 2: Continuous Glucose Monitoring Market Breakdown, U.S., 2013
Chart 7 3: Continuous Glucose Monitoring Market Breakdown, U.S., 2020
Chart 7 4: Continuous Glucose Monitoring System Market, U.S., 2010 – 2020
Chart 7 5: Continuous Glucose Monitoring Sensor Market, U.S., 2010 – 2020
Chart 7 6: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2013
Chart 8 1: Insulin Pump Market by Segment, U.S., 2010 – 2020
Chart 8 2: Insulin Pump Market Breakdown, U.S., 2013
Chart 8 3: Insulin Pump Market Breakdown, U.S., 2020
Chart 8 4: Total Traditional Insulin Pump Market, U.S., 2010 – 2020
Chart 8 5: Traditional Insulin Pump (Device) Market, U.S., 2010 – 2020
Chart 8 6: Traditional Insulin Pump Infusion Set Market, U.S., 2010 – 2020
Chart 8 7: Traditional Insulin Pump Reservoir Market, U.S., 2010 – 2020
Chart 8 8: Total Patch Insulin Pump Market, U.S., 2010 – 2020
Chart 8 9: Patch Pump Controller Market, U.S., 2010 – 2020
Chart 8 10: Insulin Pod Market, U.S., 2010 – 2020
Chart 8 11: Simple Insulin Pump Market, U.S., 2010 – 2020
Chart 8 12: Leading Competitors, Insulin Pump Market, U.S., 2013
Chart 9 1: Modern Insulin Market by Segment, U.S., 2010 – 2020
Chart 9 2: Modern Insulin Market Breakdown, U.S., 2013
Chart 9 3: Modern Insulin Market Breakdown, U.S., 2020
Chart 9 4: Total Modern Insulin Market, U.S., 2010 – 2020
Chart 9 5: Long-Acting Modern Insulin Market, U.S., 2010 – 2020
Chart 9 6: Rapid-Acting Modern Insulin Market, U.S., 2010 – 2020
Chart 9 7: Premixed Modern Insulin Market, U.S., 2010 – 2020
Chart 9 8: Leading Competitors, Modern Insulin Market, U.S., 2013
Chart 10 1: Insulin Syringe Market by Segment, U.S., 2010 – 2020
Chart 10 2: Insulin Syringe Market Breakdown, U.S., 2013
Chart 10 3: Insulin Syringe Market Breakdown, U.S., 2020
Chart 10 4: Total Insulin Syringe Market, U.S., 2010 – 2020
Chart 10 5: Professional Insulin Syringe Market, U.S., 2010 – 2020
Chart 10 6: Personal Insulin Syringe Market, U.S., 2010 – 2020
Chart 10 7: Leading Competitors, Insulin Syringe Market, U.S., 2013
Chart 11 1: Total Modern Insulin Pen Market, U.S., 2010 – 2020
Chart 11 2: Prefilled Pen Market, U.S., 2010 – 2020
Chart 11 3: Pen Cartridge Market, U.S., 2010 – 2020
Chart 11 4: Reusable Pen Market, U.S., 2010 – 2020
Chart 11 5: Pen Needle Market, U.S., 2010 – 2020
Chart 11 6: Leading Competitors, Insulin Pen Market, U.S., 2013

LIST OF FIGURES

Figure 3 1: Major Types of Diabetes and Related Pathologies
Figure 3 2: Risk Factors Associated with Type 1 and Type 2 Diabetes
Figure 3 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes
Figure 3 4: Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 3 5: Diabetes Diagnosis, Treatment and Drug Delivery Market Growth by Segment U.S., 2010 – 2020
Figure 3 6: Drivers and Limiters, Diabetes Diagnosis, Treatment and Drug Delivery Market, U.S., 2013
Figure 3 7: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, U.S., 2013
Figure 3 8: Herfindahl Index, Diabetes Diagnosis, Treatment and Drug Delivery Market, U.S., 2013
Figure 4 1: Blood Glucose Ranges Recommended by the American Diabetes Association, U.S., 2013
Figure 4 2: Traditional Blood Glucose Meter Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 4 3: Total Traditional Blood Glucose Meter Market, U.S., 2010 – 2020
Figure 4 4: Professional Blood Glucose Meter Market, U.S., 2010 – 2020
Figure 4 5: Personal Blood Glucose Meter Market, U.S., 2010 – 2020
Figure 4 6: Drivers and Limiters, Traditional Blood Glucose Meter Market, U.S., 2013
Figure 4 7: Leading Competitors, Traditional Blood Glucose Meter Market, U.S., 2013
Figure 5 1: Blood Glucose Test Strip Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 5 2: Total Blood Glucose Test Strip Market, U.S., 2010 – 2020
Figure 5 3: Professional Blood Glucose Test Strip Market, U.S., 2010 – 2020
Figure 5 4: Total Personal Blood Glucose Test Strip Market, U.S., 2010 – 2020
Figure 5 5: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2010 – 2020
Figure 5 6: Managed Care Blood Glucose Test Strip Market, U.S., 2010 – 2020
Figure 5 7: Cash Blood Glucose Test Strip Market, U.S., 2010 – 2020
Figure 5 8: Unit Sales Analysis, Long-Term Care Blood Glucose Test Strips, U.S., 2010 – 2020
Figure 5 9: Drivers and Limiters, Blood Glucose Test Strip Market, U.S., 2013
Figure 5 10: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2013
Figure 6 1: Lancet and Lancing Device Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 6 2: Total Lancet and Lancing Device Market, U.S., 2010 – 2020
Figure 6 3: Professional Lancet and Lancing Device Market, U.S., 2010 – 2020
Figure 6 4: Personal Lancet and Lancing Device Market, U.S., 2010 – 2020
Figure 6 5: Drivers and Limiters, Lancet and Lancing Device Market, U.S., 2013
Figure 6 6: Leading Competitors, Lancet and Lancing Device Market, U.S., 2013
Figure 7 1: Continuous Glucose Monitoring Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 7 2: Continuous Glucose Monitoring System Market, U.S., 2010 – 2020
Figure 7 3: Continuous Glucose Monitoring Sensor Market, U.S., 2010 – 2020
Figure 7 4: Drivers and Limiters, Continuous Glucose Monitoring Market, U.S., 2013
Figure 7 5: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2013
Figure 8 1: Insulin Pump Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 8 2: Total Traditional Insulin Pump Market, U.S., 2010 – 2020
Figure 8 3: Traditional Insulin Pump (Device) Market, U.S., 2010 – 2020
Figure 8 4: Traditional Insulin Pump Infusion Set Market, U.S., 2010 – 2020
Figure 8 5: Traditional Insulin Pump Reservoir Market, U.S., 2010 – 2020
Figure 8 6: Total Patch Insulin Pump Market, U.S., 2010 – 2020
Figure 8 7: Patch Pump Controller Market, U.S., 2010 – 2020
Figure 8 8: Insulin Pod Market, U.S., 2010 – 2020
Figure 8 9: Simple Insulin Pump Market, U.S., 2010 – 2020
Figure 8 10: Drivers and Limiters, Insulin Pump Market, U.S., 2013
Figure 8 11: Leading Competitors, Insulin Pump Market, U.S., 2013
Figure 9 1: Onset, Peak and Duration of Insulin Types, U.S., 2013
Figure 9 2: Modern Insulin Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 9 3: Total Modern Insulin Market, U.S., 2010 – 2020
Figure 9 4: Long-Acting Modern Insulin Market, U.S., 2010 – 2020
Figure 9 5: Rapid-Acting Modern Insulin Market, U.S., 2010 – 2020
Figure 9 6: Premixed Modern Insulin Market, U.S., 2010 – 2020
Figure 9 7: Drivers and Limiters, Modern Insulin Market, U.S., 2013
Figure 9 8: Leading Competitors, Modern Insulin Market, U.S., 2013
Figure 10 1: Insulin Syringe Market by Segment, U.S., 2010 – 2020 (US$M)
Figure 10 2: Total Insulin Syringe Market, U.S., 2010 – 2020
Figure 10 3: Professional Insulin Syringe Market, U.S., 2010 – 2020
Figure 10 4: Personal Insulin Syringe Market, U.S., 2010 – 2020
Figure 10 5: Drivers and Limiters, Insulin Syringe Market, U.S., 2013
Figure 10 6: Leading Competitors, Insulin Syringe Market, U.S., 2013
Figure 11 1: Total Modern Insulin Pen Market, U.S., 2010 – 2020
Figure 11 2: Prefilled Pen Market, U.S., 2010 – 2020
Figure 11 3: Pen Cartridge Market, U.S., 2010 – 2020
Figure 11 4: Reusable Pen Market, U.S., 2010 – 2020
Figure 11 5: Pen Needle Market, U.S., 2010 – 2020
Figure 11 6: Drivers and Limiters, Modern Insulin Pen Market, U.S., 2013
Figure 11 7: Leading Competitors, Modern Insulin Pen Market, U.S., 2013


More Publications